Dexmedetomidine Use in Hemodynamically Stable Stroke Patients

Indications and Contraindications

Dexmedetomidine may be considered for light sedation during non-interventional ICU care after the acute phase in hemodynamically stable stroke patients, as it produces minimal respiratory depression 1, 2
The American College of Critical Care Medicine suggests using dexmedetomidine over benzodiazepines for mechanically ventilated ICU patients, due to reduced delirium and faster extubation, but these recommendations were not stroke-specific and predate the 2024 stroke outcome data 4, 5

If dexmedetomidine is deemed necessary in a hemodynamically stable stroke patient, avoid the loading dose entirely due to the biphasic cardiovascular response, and start maintenance infusion at the lowest effective dose: 0.2 mcg/kg/hour 1, 2
Titrate slowly up to maximum 0.7 mcg/kg/hour, avoiding higher doses of 1.5 mcg/kg/hour in stroke patients, and prepare as 4 mcg/mL concentration in 0.9% normal saline for precise titration 1

Continuous hemodynamic monitoring is mandatory due to stroke patients' heightened vulnerability to hypotension, with blood pressure checks every 2-3 minutes during initiation, and maintain MAP > 70 mm Hg to ensure adequate cerebral perfusion 1, 2
Have vasopressors immediately available, and monitor for bradycardia with atropine readily accessible 1, 2

Absolute contraindications for dexmedetomidine in stroke patients include hemodynamic instability or hypotension at baseline, severe bradycardia or heart block, and during active endovascular thrombectomy procedures 1, 2, 3
Relative contraindications include severe hepatic dysfunction, and elderly patients with cardiac disease, who should consider omitting loading dose or extending infusion time 1, 3